Annette North

VP, Legal and Corporate Sec, SGX PHARMACEUTICALS, INC.

Companies

Turning Point Therapeutics, Inc.General counsel Apr 16, 2019 to Feb 11, 2022¹
Kura OncologyGeneral counsel Mar 16, 2015 to Jan 24, 2019²
Ambit BiosciencesGeneral counsel Sep 26, 2013 to Nov 12, 2014³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Turning Point Therapeutics, Inc.27,979 shares⁴Feb 9, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 9, 2022Granted 16,283 shares of Turning Point Therapeutics, Inc.⁴
Feb 9, 2022Sold 669 shares at $36.30 of Turning Point Therapeutics, Inc.⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTurning Point Therapeutics, Inc., General counsel
2
SEC EDGARKura Oncology, General counsel
3
SEC EDGARAmbit Biosciences, General counsel
4
SEC EDGARTurning Point Therapeutics, Inc. shares after the filing of Feb 9, 2022